In a retrospective, single center study, Madoz-Gúrpide et al. found MET overexpression in 58%, MET amplification in 39%, MET protein phosphorylation in 30%, and HGF overexpression in 58% of the analyzed tumors of patients with HNSCC [56]. This evidence concerns the gene HGF and head and neck squamous cell carcinoma.